THE TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT INTERFERON-ALPHA-2C

被引：0
|
作者：
GISSLINGER, H
LINKESCH, W
HOCKER, P
SINZINGER, H
FLENER, R
LUDWIG, H
机构：
[1] VIENNA UNIV,MED KLIN 2,A-1010 VIENNA,AUSTRIA
[2] ALLGEMEINEN KRANKENHAUSES,INTENSIVBLUTBANK,WIEN,AUSTRIA
[3] BOEHRINGER INST,WIEN,AUSTRIA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 1986年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：590 / 590
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT INTERFERON-ALPHA-2C
    GISSLINGER, H
    LINKESCH, W
    HOCKER, P
    CHOTT, A
    SINZINGER, H
    LUDWIG, H
    [J]. ACTA MEDICA AUSTRIACA, 1986, 13 : 67 - 67
  • [2] TREATMENT OF ADVANCED MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT INTERFERON-ALPHA2B
    AUL, C
    GATTERMANN, N
    SCHNEIDER, W
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 46 (01) : 11 - 16
  • [3] ADJUVANT TREATMENT OF RECALCITRANT GENITOANAL WARTS WITH SYSTEMIC RECOMBINANT INTERFERON-ALPHA-2C
    HOPFL, RM
    SANDBICHLER, M
    ZELGER, BWH
    CONRAD, FG
    FRITSCH, PO
    [J]. ACTA DERMATO-VENEREOLOGICA, 1992, 72 (05) : 383 - 386
  • [4] ALLERGY OF DELAYED-TYPE TO RECOMBINANT INTERFERON-ALPHA-2C
    DETMAR, U
    AGATHOS, M
    NERL, C
    [J]. CONTACT DERMATITIS, 1989, 20 (02) : 149 - 150
  • [5] TREATMENT WITH RECOMBINANT INTERFERON-ALPHA-2C - MULTIPLE-MYELOMA AND THROMBOCYTHEMIA IN MYELOPROLIFERATIVE DISEASES
    LUDWIG, H
    CORTELEZZI, A
    VANCAMP, BGK
    POLLI, E
    SCHEITHAUER, W
    KUZMITS, R
    LINKESCH, W
    GISSLINGER, H
    SINZINGER, H
    FRITZ, E
    FLENER, R
    [J]. ONCOLOGY, 1985, 42 : 19 - 25
  • [6] RECOMBINANT ALPHA-2B INTERFERON IN THE MANAGEMENT OF MYELODYSPLASTIC SYNDROMES
    LIM, SH
    DONOHUE, SM
    BOUGHTON, BJ
    [J]. BLUT, 1988, 56 (06): : C21 - C21
  • [7] THERAPEUTIC EFFECT OF HUMAN RECOMBINANT INTERFERON-ALPHA-2C IN ESSENTIAL THROMBOCYTHEMIA
    VELU, T
    DELWICHE, F
    GANGJI, D
    MONSIEUR, R
    FLAMENT, J
    STRYCKMANS, P
    WYBRAN, J
    BELLENS, R
    [J]. ONCOLOGY, 1985, 42 : 10 - 14
  • [8] PHARMACOKINETICS AND BIODISPOSITION OF RECOMBINANT HUMAN INTERFERON-ALPHA-2C IN RAT AND MARMOSET
    GREISCHEL, A
    TANSWELL, P
    BUSCH, U
    SCHUMACHER, K
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (10): : 1539 - 1543
  • [9] EFFECT OF RECOMBINANT INTERFERON-ALPHA-2C ON RETICULOENDOTHELIAL FUNCTION IN PATIENTS WITH THROMBOCYTOSIS
    SCHEITHAUER, W
    GISSLINGER, H
    TEMSCH, EM
    LINKESCH, M
    LINKESCH, W
    LUDWIG, H
    [J]. JOURNAL OF INTERFERON RESEARCH, 1990, 10 (02): : 237 - 242
  • [10] RESULTS OF RECOMBINANT INTERFERON-ALPHA2B IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES
    AUL, C
    GUNTHER, B
    PLANKER, M
    SCHAFERS, M
    SCHNEIDER, W
    [J]. BLUT, 1988, 57 (04): : 224 - 224
12345